In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs
- PMID: 15019203
- PMCID: PMC7124310
- DOI: 10.1016/j.peptides.2003.07.025
In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs
Abstract
Two alpha-helical antimicrobial peptides (BMAP-27 and -28) and four synthetic analogs were compared for in vitro and in vivo antimicrobial efficacy. All peptides proved active in vitro at micromolar concentrations against a range of clinical isolates, including antibiotic-resistant strains. BMAP-27 and two analogs were more effective towards Gram-negative, and BMAP-28 towards Gram-positive organisms. In addition, BMAP-28 provided some protection in vitro against human herpes simplex virus type 1 (HSV-1). The parent peptides and mBMAP-28 analog protected mice from lethal i.p. infections in an acute peritonitis model at peptide doses significantly lower than those toxic to the animals, suggesting a satisfactory therapeutic index.
Figures


Similar articles
-
Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity.Biochemistry. 2009 Nov 24;48(46):10905-17. doi: 10.1021/bi9009874. Biochemistry. 2009. PMID: 19845398
-
Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.Peptides. 2011 Jun;32(6):1123-30. doi: 10.1016/j.peptides.2011.03.024. Epub 2011 Apr 8. Peptides. 2011. PMID: 21497177
-
Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40. doi: 10.1128/AAC.00452-08. Epub 2008 Jun 30. Antimicrob Agents Chemother. 2008. PMID: 18591279 Free PMC article.
-
Human antimicrobial peptides: defensins, cathelicidins and histatins.Biotechnol Lett. 2005 Sep;27(18):1337-47. doi: 10.1007/s10529-005-0936-5. Biotechnol Lett. 2005. PMID: 16215847 Review.
-
Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice.Protein Pept Lett. 2014;21(12):1247-56. Protein Pept Lett. 2014. PMID: 25101632 Review.
Cited by
-
Cathelicidins Modulate TLR-Activation and Inflammation.Front Immunol. 2020 Jun 9;11:1137. doi: 10.3389/fimmu.2020.01137. eCollection 2020. Front Immunol. 2020. PMID: 32582207 Free PMC article. Review.
-
A Novel Strategy for the Design of Aurein 1.2 Analogs with Enhanced Bioactivities by Conjunction of Cell-Penetrating Regions.Antibiotics (Basel). 2023 Feb 19;12(2):412. doi: 10.3390/antibiotics12020412. Antibiotics (Basel). 2023. PMID: 36830322 Free PMC article.
-
Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.Int J Med Sci. 2013 Apr 16;10(6):719-29. doi: 10.7150/ijms.5037. Print 2013. Int J Med Sci. 2013. PMID: 23630436 Free PMC article.
-
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.BMC Microbiol. 2012 Jul 23;12:145. doi: 10.1186/1471-2180-12-145. BMC Microbiol. 2012. PMID: 22823964 Free PMC article.
-
The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection.BMC Microbiol. 2010 Jun 23;10:178. doi: 10.1186/1471-2180-10-178. BMC Microbiol. 2010. PMID: 20573188 Free PMC article.
References
-
- Ahmad I., Perkins W.R., Lupan D.M., Selsted M.E., Janoff A.S. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim. Biophys. Acta. 1995;1237:109–114. - PubMed
-
- Borenfreund E., Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red adsorption. Toxicol Lett. 1985;24:119–124. - PubMed
-
- Buck M.A., Olah T.A., Weitzmann C.J., Cooperman B.S. Protein estimation by the product of integrated peak area and flow rate. Anal. Biochem. 1989;182:295–299. - PubMed
-
- Chen J., Falla T.J., Liu H., Hurst M.A., Fujii C.A., Mosca D.A. Development of protegrins for the treatment and prevention of oral mucositis: structure–activity relationships of synthetic protegrin analogues. Biopolymers. 2000;55:88–98. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources